Search results

news-media-release
Update on nuclear medicine generator delivery from the USA 04/07/2018

A spokesperson from ANSTO has provided a statement

news-media-release
Technetium-99m (Tc-99m) Generator production at ANSTO 27/06/2018

Technetium-99m (Tc-99m) is used in hospitals around the world to diagnose a variety of heart, lung and musculoskeletal conditions, as well as cancers. It is the most common nuclear medicine, with global demand estimated to be up to 40 million doses a year, produced by experts with a small network of 11* nuclear reactors worldwide.

News generic media centre thumbnail
Australia steps up to prevent a world nuclear medicine shortfall 11/11/2016

Australia is making a significant global contribution by stepping up to help prevent a shortfall in world nuclear medicine supplies with two projects worth about $170 million.

OPAL 10 year group 200 x 145
World leader visits future site of world's nuclear medicine production in Australia 09/08/2016

Director-General of the IAEA, Yukiya Amano visited Lucas Heights and inspected progress on the ANSTO Nuclear Medicine production facility, which is in the final phases of construction.

Synroc 200x145
Synroc: Australian innovation increases technology readiness for waste treatment plant 18/02/2016

An update on Synroc, an Australian innovation to store nuclear waste from nuclear medicine production

Hot cells concrete pour news thumbnail
High density concrete poured on Mo-99 hot cells 23/12/2015

We have uploaded a short timelapse video of the concrete pour for shielding of the Mo-99 hot cells.

Turnbull_Ministry_news-thumbnail
New Minister for Industry, Innovation and Science 21/09/2015

Australia's new Prime Minister Malcolm Turnbull has made the Hon Christopher Pyne MP the Minister for, Industry, Innovation and Science.

Four million nuclear medicine doses produced, and going strong 07/06/2015

ANSTO has just delivered its four millionth dose of nuclear medicine, used to diagnose a wide range of illnesses, including cardiac conditions, cancers and skeletal injuries that will benefit one in every two Australians at some point during their lifetime.

Construction of ANM media centre thumbnail
Ground floor of new ANM facility nears completion 02/02/2015

Australia’s new nuclear medicine manufacturing facility is taking shape – a project which will enable Australia to help meet world demand for the most common radionuclide used in nuclear medicine, Molybdenum-99.

Diagnosing illness media centre thumbnail
New program to make more accurate nuclear medicine treatments possible 06/01/2015

You can’t see it, hear it or smell it, and it’s constantly changing: but despite that, Australia’s nuclear scientists have figured out how to more accurately measure the unit of activity for radionuclides, the Becquerel (Bq).

Find more...

Media enquiry form

If you have a media enquiry please call
Phil McCall: +61 438 619 987

Or

Send »

Please provide us with your name, phone number and
email so we can get back to you.

Error: Enquiry was not sent! Check all fields have been populated correctly.
Success: Enquiry was sent successfully.

Publications »